Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 43Triple Negative Breast Neoplasms 19Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 14Neoplasm Metastasis 10Lung Neoplasms 10Squamous Cell Carcinoma of Head and Neck 7Parkinson Disease 4, Autosomal Dominant Lewy Body 7Neoplasms 6Adenocarcinoma 6Cholangiocarcinoma 5Stomach Neoplasms 4Gallbladder Neoplasms 4Biliary Tract Neoplasms 4Uterine Cervical Neoplasms 3Recurrence 3Pancreatic Adenocarcinoma 3Ovarian Neoplasms 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Endometrial Neoplasms 3Colorectal Neoplasms 3Small Cell Lung Carcinoma 2Sarcoma 2Rectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Pancreatic Ductal 2Carcinoma, Hepatocellular 2

Interventions

paricalcitol 1folfirinox 1Taxes 1Gemcitabine 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Resectable Pancreatic Cancer × Albumin-Bound Paclitaxel × 1 year × Clear all
NCT03138720 2026-04-22

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

HonorHealth Research Institute

Phase 2 Completed
40 enrolled 22 charts
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡